Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genentech
Biotech
Kineta sells Genentech, Merck deals to investor ahead of merger
Tidying up the portfolio ahead of its merger with TuHURA, Kineta is selling the deals to an investment firm and offloading a pain prospect to Pacira.
Nick Paul Taylor
Feb 10, 2025 7:45am
Atalanta loads crossbow with $97M, 2 Big Pharmas in tow
Jan 28, 2025 7:00am
FDA pulls diversity guidance for clinical trials from website
Jan 27, 2025 11:00am
JPM25: Roche has $10B in M&A firepower per year, pharma CEO says
Jan 13, 2025 4:45pm
40% layoffs break Belharra's tidal wave
Dec 9, 2024 4:52pm
Cour inks $940M-plus autoimmune deal with Roche's Genentech
Dec 3, 2024 7:58am